Impact of white-coat hypertension on microvascular complications in type 2 diabetes

Diabetes Care

Volumn 31, Issue 12, 2008, Pages 2233-2237

  Kramer, Caroline K ^a   Leitão, Cristiane B ^a   Canani, Luís H ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; WHITE COAT HYPERTENSION;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 61849112671     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1299     Document Type: Article

References (25)

1. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49:1761-1769, 2006
2. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317:703-713, 1998
3. Leitao CB, Canani LH, Bolson PB, Molon MP, Pinotti AF, Gross JL: Urinary albumin excretion rate is associated with increased ambulatory blood pressure in nor- moalbuminuric type 2 diabetic patients. Diabetes Care 28:1724-1729, 2005
4. Leitao CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL: Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 30:1255-1260,2007
5. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bom- belli M, Giannattasio C, Zanchetti A, Man- cia G: Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] study). Circulation 104:1385-1392,2001
6. Flores L, Gimenez M, Esmatjes E: Prognostic significance of the white coat hypertension in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 74:21-25, 2006
7. Canani LH, Gerchman F, Gross JL: Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy. Diabetes Care 21:1545-1550, 1998
8. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML: Exercise standards: a statement for healthcare professionals from the American Heart Association. Circulation 91:580615, 1995
9. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164-176, 2005
10. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677-1682, 2003
11. LeveyAS, CoreshJ, BalkE, KauszAT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147, 2003
12. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Mat- subara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20: 2183-2189, 2002
13. Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini M, Salvatore L, Antidormi T, Costantini F, Cuccurullo F: 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J16:692-697, 1995
14. III Guidelines for the Use of Ambulatory Blood Pressure Monitoring-ambulatory monitoring of blood pressure. Sociedade Brasileira de Hipertensao. Arq Bras Cardiol 77:384-389, 2001
15. Flores L, Recasens M, Gomis R, Esmatjes E: White coat hypertension in type 1 diabetic patients without nephropathy. Am J Hypertens 13:560-563, 2000
16. PuigJG, Ruilope LM, Ortega R: Antihypertensive treatment efficacy in type II diabetes mellitus: ;Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension 26:1093-1099, 1995
17. Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH: White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes Care 20:859-863, 1997
18. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A: Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation100:1071-1076, 1999
19. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG: Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 38:238-245, 2001
20. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111:1777-1783, 2005
21. Chrysant SG: Treatment of white coat hypertension. Curr Hypertens Rep 2:412-417, 2000
22. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccu- rullo F, Mezzetti A: Target organ status and serum lipids in patients with white coat hypertension. Hypertension 26:801-807, 1995
23. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB: White-coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med 160: 1507-1512, 2000
24. Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Pet- rin J, Sekkarie MA, Kjeldsen SE, et al.: "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 16:617-623, 1990
25. Rassam SM, Patel V, Kohner EM: The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp Physiol 80:53-68, 1995